Shareholders approve merger with Semnur Pharmaceuticals at September 3 meeting

Semnur Pharmaceuticals, Inc.

All 9 proposals, including business combination with Semnur, approved by 94.08% quorum.
Domestication from Cayman Islands to Delaware and amended charter/bylaws approved.
New board of directors elected: Jaisim Shah, Henry Ji, Jay Chun, Dorman Followwill, Yue Alexander Wu.
Issuance of >20% of Denali shares and conversion of Semnur options into New Semnur options approved.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.